Serum LHBS was better than traditional serum HBS in the stratification of HBe(−) CHB patients and HCC patients, in the correlation of HCC recurrence and in the prediction of DFS and OS in HCC patients after surgery. This evidence concerns the gene HBE1 and hepatocellular carcinoma.